Another interesting chemokine that is strongly upregulated in cancer cell lines, particularly by olaparib treatment, is CCL20. CCL20 could be associated with cancer metastasis and progression by interacting with its cognate receptor CCR6 in an ovarian cancer mouse model. Here, CCR6 is linked to ovarian carcinoma.